Table5: Assessment of Treatment Efficacy at Visits 2 and 3(Baseline Population n = 4,092)

Assessment of Treatment Efficacy
Investigator (%) Patient (%)
Visit 2 Visit 3 Visit 2 Visit 3
Very good 25.9 37.0 27.1 38.8
Good 45.2 47.4 41.8 45.2
Fair 21.2 9.6 21.3 9.4
Bad 6.0 2.8 7.3 3.2
Very bad 0.6 0.5 1.5 0.7
No data 1.1 2.7 1.0 2.7
Total 100 100 100 100